(PR Newswire, February 5) – FMC Corporation (FMC) today reported record quarterly revenues of $1.1 billion in the fourth quarter, a 24 percent increase over the same period in 2012. The company reported net income of $27.1 million, or $0.20 per diluted share, in the fourth quarter of 2013, versus net income of $102.2 million, or $0.74 per diluted share, in the fourth quarter of 2012. Fourth quarter results include charges primarily related to the sale of the Peroxygens business of $114.3 million after tax, or $0.85 per diluted share, compared to charges of $4.4 million after tax, or $0.03 per diluted share, in the prior-year quarter. Excluding these items in both periods, adjusted earnings were $1.05 per diluted share, an increase of 36 percent versus the prior-year quarter. For the full year, revenues grew to $3.9 billion, up 14 percent over 2012. Adjusted full-year earnings per diluted share increased 15 percent to $3.88 versus $3.39 in 2012.